Clinical Trial Update: Peroral Levosimendan in Chronic Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 trial of peroral levosimendan for chronic heart failure has completed. This entry summarizes the trial status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Disease
• Heart Failure

Drugs mentioned

• Levosimendan (levosimendan)

Snippet

Sponsor: Orion Corporation, Orion Pharma | Conditions: Chronic Heart Failure, Heart Diseases | Phase 2 | Status: COMPLETED